Literature DB >> 9592116

Activation of coeruleospinal noradrenergic inhibitory controls during withdrawal from morphine in the rat.

D S Rohde1, A I Basbaum.   

Abstract

We previously reported that withdrawal from morphine induces the expression of Fos, a marker of neuronal activity, in spinal cord neurons, particularly in laminae I and II of the superficial dorsal horn, and that the magnitude of Fos expression is increased in rats with a midthoracic spinal transection. We suggested that loss of withdrawal-associated increases in descending inhibitory controls that arise in the brainstem underlie the increased Fos expression after spinal transection. Here, we addressed the origin of the supraspinal inhibition. We injected rats intracerebroventricularly with saline or anti-dopamine-beta-hydroxylase-saporin, a toxin that destroys noradrenergic neurons of the locus coeruleus. Eleven days later, we implanted rats with morphine or placebo pellets, and after 4 d, we precipitated withdrawal with naltrexone. One hour later, the rats were killed, their brains and spinal cords were removed, and transverse sections of the brains and spinal cords were immunoreacted with an antibody to Fos. In placebo-pelleted rats, the toxin injection did not alter behavior and did not induce expression of the Fos protein. However, compared with saline-injected withdrawing rats, the toxin-treated rats that underwent withdrawal demonstrated an intense withdrawal behavior rarely seen in the absence of toxin, namely forepaw fluttering. The rats also had significantly increased Fos-like immunoreactivity in all laminae of the cervical cord and in laminae I and II and the ventral horn of the lumbar cord. No differences were recorded in the sacral cord. We conclude that the effects of spinal transection in rats that withdraw from morphine in part reflect a loss of coeruleospinal noradrenergic inhibitory controls.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9592116      PMCID: PMC6792821     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance.

Authors:  S K Sharma; W A Klee; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

Review 2.  The projections of locus coeruleus neurons to the spinal cord.

Authors:  H K Proudfit; F M Clark
Journal:  Prog Brain Res       Date:  1991       Impact factor: 2.453

3.  Effects on nociceptive threshold and blood pressure of intrathecally administered morphine and alpha-adrenergic agonists.

Authors:  S Yasuoka; T L Yaksh
Journal:  Neuropharmacology       Date:  1983-03       Impact factor: 5.250

4.  Locus coeruleus modulation of dorsal horn unit responses to cutaneous stimulation.

Authors:  C J Hodge; A V Apkarian; R Stevens; G Vogelsang; H J Wisnicki
Journal:  Brain Res       Date:  1981-01-12       Impact factor: 3.252

5.  Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings.

Authors:  C C Wrenn; M J Picklo; D A Lappi; D Robertson; R G Wiley
Journal:  Brain Res       Date:  1996-11-18       Impact factor: 3.252

6.  Spinal sympathetic neurons: possible sites of opiate-withdrawal suppression by clonidine.

Authors:  D N Franz; D B Hare; K L McCloskey
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

7.  Walking evokes a distinctive pattern of Fos-like immunoreactivity in the caudal brainstem and spinal cord of the rat.

Authors:  L Jasmin; K R Gogas; S C Ahlgren; J D Levine; A I Basbaum
Journal:  Neuroscience       Date:  1994-01       Impact factor: 3.590

8.  A demonstration of naloxone-precipitated opiate withdrawal on single neurones in the morphine-tolerant/dependent rat brain.

Authors:  J P Fry; A Herz; W Zieglgänsberger
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

9.  Noradrenergic projections to the spinal cord of the rat.

Authors:  K N Westlund; R M Bowker; M G Ziegler; J D Coulter
Journal:  Brain Res       Date:  1983-03-14       Impact factor: 3.252

10.  NMDA antagonists and clonidine block c-fos expression during morphine withdrawal.

Authors:  K Rasmussen; M Brodsky; C E Inturrisi
Journal:  Synapse       Date:  1995-05       Impact factor: 2.562

View more
  7 in total

Review 1.  The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence.

Authors:  Yong Chen; Claudia Sommer
Journal:  Mol Neurobiol       Date:  2009-05-26       Impact factor: 5.590

2.  Brain stem catecholamines circuitry: activation by alcohol and role in the hypothalamic-pituitary-adrenal response to this drug.

Authors:  S Lee; Z Craddock; C Rivier
Journal:  J Neuroendocrinol       Date:  2011-06       Impact factor: 3.627

3.  Schwann cells are removed from the spinal cord after effecting recovery from paraplegia.

Authors:  L Jasmin; G Janni; T M Moallem; D A Lappi; P T Ohara
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

4.  Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.

Authors:  S Sawamura; W S Kingery; M F Davies; G S Agashe; J D Clark; B K Kobilka; T Hashimoto; M Maze
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

Review 5.  Immediate and prolonged effects of alcohol exposure on the activity of the hypothalamic-pituitary-adrenal axis in adult and adolescent rats.

Authors:  Camryn D Allen; Soon Lee; George F Koob; Catherine Rivier
Journal:  Brain Behav Immun       Date:  2011-02-12       Impact factor: 7.217

6.  Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain.

Authors:  J J Brightwell; B K Taylor
Journal:  Neuroscience       Date:  2009-02-14       Impact factor: 3.590

7.  Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Roberto Frau; Gian L Gessa
Journal:  Brain Behav       Date:  2015-09-24       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.